Synthesis and evaluation of aryl-substituted N-(arylethyl)-N-methyl-2- (1-pyrrolidinyl)ethylamines and corresponding arylacetamides for sigma receptor affinity

Journal of Medicinal Chemistry

Volumn 39, Issue 18, 1996, Pages 3564-3568

  Zhang, Ying ^a   Williams, Wanda ^a   Bowen, Wayne D ^a   Rice, Kenner C ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAMIDE DERIVATIVE; DEXTRALLORPHAN; ETHYLENEDIAMINE DERIVATIVE; HALOPERIDOL; PENTAZOCINE; SIGMA OPIATE RECEPTOR;

ANIMAL TISSUE; ARTICLE; BRAIN MEMBRANE; DRUG BINDING SITE; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; GUINEA PIG; LIGAND BINDING; LIVER MEMBRANE; MALE; MASS SPECTROMETRY; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; RAT;

ACETAMIDES; ANIMALS; ETHYLAMINES; GUINEA PIGS; RATS; RECEPTORS, SIGMA; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0029815434     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9600813     Document Type: Article

References (32)

1. Walker, J. M.; Matsumoto, R. R.; Bowen, W. D.; Gans, D. L.; Jones, K. D.; Walker, F. O. Evidence for a role of haloperidol-sensitive sigma opiate receptors in the motor effects of antip-sychotic drugs. Neurology 1988, 38, 961-965.
2. Goldstein, S. R.; Matsumoto, R. R.; Thompson, T. L.; Patrick, R. L.; Bowen, W. D.; Walker, J. M. Motor effects of two sigma ligands mediated by nigrostriatal dopamine neurons. Synapse 1989, 4, 254-258.
3. Matsumoto, R. R.; Hemstreet, M. K.; Lai, N.; Thurkauf, A.; de Costa, B. R.; Rice, K. C.; Hellewell, S. B.; Bowen, W. D.; Walker, J. M. Drug specificity of pharmacological dystonia. Pharmacol. Biochem. Behav. 1990, 36, 151-155.
4. Bowen, W. D.; Kirschner, B. N.; Newman, A. H.; Rice, K. C. Sigma receptors negatively modulate agonist-stimulated phosphoinositide metabolism in rat brain. Eur. J. Pharmacol. 1988, 149, 399-400.
5. Bowen, W. D.; Tolentino, P. J.; Hsu, K. K.; Cutts, J. M.; Naidu, S.S. Inhibition of the cholinergic phosphoinositide response by sigma ligands: Distinguishing a sigma receptor-mediated mechanism from a mechanism involving direct cholinergic antagonism. Multiple Sigma and PCP Receptor Ligands: Mechanisms for Neuromodulation and Neuroprotection; Kamenka, J.-M., Domino, E. F., Eds.; NPP Books: Ann Arbor, MI, 1992, pp 155-167.
6. (a) Monnet, F. P.; Debonnel, G.; de Montigny, C. In vivo electrophysiological evidence for a selective modulation of N-methyl-D-aspartate-induced neuronal activation in rat CA3 dorsal hippocampus by sigma ligands. J. Pharmacol. Exp. Ther. 1992, 261, 123-130.
7. 3H]dopamine release from rat striatal slices by sigma receptor ligands. J. Pharmacol. Ther. 1994, 271, 212-219.
8. Vaupel, D. B.; Su, T. P. Guinea pig vas deferens preparation may contain both sigma receptors and phencyclidine receptors. Eur. J. Pharmacol. 1987, 139, 125-128.
9. Massamiri, T.; Duckles, S. P. Multiple vascular effects of Sigma and PCP ligands. Inhibition of amine uptake and contractile responses. J. Pharmacol. Exp. Ther. 1990, 253, 124-129.
10. Long, J. B.; Tidwell, R. E.; Tortella, F. C.; Rice, K. C.; de Costa, B. R. Selective sigma ligands protect aginst dynorphin A-induced spinal cord injury in rats. Soc. Neurosci. Abstr. 1990, 16, 1122, abstr. 461.4.
11. Contreras, P. C.; Ragan, D. M.; Bremer, M. E.; Lanthorn, T. H.; Gray, N. M.; Iyengar, S.; Jacobson, A. E.; Rice, K. C.; de Costa, B. R. Evaluation of U50,488H analogs for neuroprotective activity in the gerbil, Brain Res. 1991, 546, 79-82.
12. Vilner, B. J.; Bowen, W. D. Sigma receptor-active neuroleptics are cytotoxic to C6 glioma cells in culture. Eur, J. Pharmacol., Mol. Pharmacol. Sect. 1993, 244, 199-201.
13. Bowen, W. D.; Vilner, B. J. Sigma receptor-mediated morphological and cytotoxic effects on primary cultures of rat central and peripheral nervous system. Soc. Neurosci. Abstr. 1994, 20, 747, abstr. 314.10.
14. Vilner, B. J.; de Costa, B. R.; Bowen, W. D. Cytotoxic effects of sigma ligands: Sigma receptor-mediated alterations in cellular morphology and viability. J. Neurosci. 1995, 15, 117-134.
15. Walker, J. M.; Bowen, W. D.; Walker, F. O.; Matsumoto, R. R.; de Costa, B. R.; Rice, K. C. Sigma receptors: biology and function. Pharmacol. Rev. 1990, 42, 355-402.
16. Hellewell, S. B.; Bowen, W. D. A sigma-like binding site in rat pheochromocytoma (PC12) cells: Decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that in guinea pig brain. Brain Res. 1990, 527, 244-253.
17. Quirion, R.; Bowen, W. D.; Itzhak, Y.; Junien, J. L.; Musacchio, J. M.; Rothman, R. B.; Su, T. P.; Tam, S. W.; Taylor, D. P. A proposal for the classification of sigma binding sites. Trends Pharmacol. Sci. 1992, 13, 85-86.
18. Riviere, P. J. M.; Pascaud, X.; Junien, J. L.; Porreca, F. Neuropeptide Y and J01784, a selective σ ligand, alter intestinal ion transport through a common, haloperidol-sensitive site. Eur. J. Pharmacol. 1980, 187, 557-559.
19. Pascaud, X.; Defaux, J. P.; Roze, C.; Junien, J. L. Effect of selective sigma ligands on duodenal alkaline secretion in the rat. J. Pharmacol. Exp. Ther. 1990, 255, 1354-1359.
20. Campbell, B. G.; Scherz, M. W.; Keana, J. F. W.; Weber, E. Sigma receptors regulate contractions of the guinea-pig ileum longitudinal muscle/myenteric plexus preparation elicited by both electrical stimulation and exogenous serotonin. J. Neurosci. 1989, 9, 3380-3391.
21. 2 receptors in motor function. Eur. J. Pharmacol. 1993, 231, 61-68.
22. (a) Wu, X. Z.; Bell, J. A.; Spivak, C. E.; London, E. D.; Su, T. P. Electrophysiological and binding studies on intact NCB-20 cells suggest presence of a low affinity sigma receptor. J. Pharmacol. Exp. Ther. 1991, 257, 351-359.
23. + channel of class III antiarrhythmic drugs? Eur. J. Pharmacol. 1993, 241, 111-116.
24. de Costa, B. R.; Radesca, L.; Di Paolo, L.; Bowen, W. D. Synthesis, characterization, and biological evaluation of a novel class of N-(arylethyl)-N-alkyl-2-(1-pyrrolidinyl)ethylamines: structural requirements and binding affinity at the σ receptor. J. Med. Chem. 1992, 35, 38-47.
25. He, X. S.; Bowen, W. D.; Lee, K. S.; Williams, W.; Weinberger, D. R.; de Costa, B. R. Synthesis and binding characteristics of potential SPECT imaging agents for σ-1 and σ-2 binding sites. J. Med. Chem. 1993, 36, 566-572.
26. Hunger, von A.; Kebrle, J.; Rossi, A.; Hoffman, A. Benzimidazol-derivate und verwandte heterocyclen III) Synthese von 1-aminoalkyl-2-benzyl-nitro-benzimidazolen. Helv. Chim. Acta 1960, 43, 1032-1046.
27. Haefely, W.; Kyburz, E.; Gerecke, M.; Mohler, H. Recent advances in the molecular pharmacology of benzodiazepine receptors and in the structure-activity relationships of their agonist. Adv. Drug Res. 1985, 14, 165-322.
28. 2).
29. 3H](+)-pentazocine, a highly potent and selective radioligand for σ receptors. Fed. Eur. Biochem. Soc. 1989, 257, 53-58.
30. 3H](+)-Pentazocine: A potent and highly selective benzomorphan-based probe for sigma-1 receptors. Mol. Neuropharmacol. 1993, 3, 117-126.
31. Hellewell, S. B.; Bruce, A.; Feinstein, G.; Orringer, J.; Williams, W.; Bowen, W. D. Rat liver and kidney contain high densities of sigma-1 and sigma-2 receptors. Characterization by ligand binding and photoaffinity labeling. Eur. J. Pharmacol., Mol. Pharmacol. Sect. 1994, 268, 9-18.
32. Yoon, N. M.; Brown, H. C. Selective Reductions. XII. Explorations in some representative applications of aluminum hydride for selective reductions. J. Am. Chem. Soc. 1968, 90, 2927-2938.